Phase I/II study of sequential chemoimmunotherapy (SCIT) for metastatic melanoma: outpatient treatment with dacarbazine, granulocyte-macrophage colony-stimulating factor, low-dose interleukin-2, and interferon-alphaGROENEWEGEN, Gerard; BLOEM, Andries; DE GAST, Gijsbert C et al.Cancer immunology and immunotherapy. 2002, Vol 51, Num 11-12, pp 630-636, issn 0340-7004, 7 p.Article

Temozolomide in advanced malignant melanoma with small brain metastases : Can we withhold cranial irradiation?BOOGERD, Willem; DE GAST, Gijsbert C; DALESIO, Otilia et al.Cancer. 2007, Vol 109, Num 2, pp 306-312, issn 0008-543X, 7 p.Article

A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumorBEX, Axel; MALLO, Henk; KERST, Martijn et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 7, pp 713-719, issn 0340-7004, 7 p.Article

Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patientsBINS, Adriaan; MALLO, Henk; SEIN, Johan et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 2, pp 234-239, issn 1524-9557, 6 p.Article

Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responsesOTTEN, Henderikus G; DE GAST, Gijsbert C; VOOIJS, Wim C et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 9, pp 569-575, issn 0340-7004, 7 p.Article

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patientsSMIT, Léonie H. M; KORSE, Catharina M; HART, Augustinus A. M et al.European journal of cancer (1990). 2005, Vol 41, Num 3, pp 386-392, issn 0959-8049, 7 p.Article

Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantationVAN DIJK, Astrid M. C; KESSLER, Floortje L; VERDONCK, Leo F et al.British journal of haematology. 2000, Vol 111, Num 3, pp 791-796, issn 0007-1048Article

Radio Frequency Ablation Combined with Interleukin-2 Induces an Antitumor Immune Response to Renal Cell Carcinoma in a Murine ModelKROEZE, Stephanie G. C; DAENEN, Laura G. M; NIJKAMP, Maarten W et al.The Journal of urology. 2012, Vol 188, Num 2, pp 607-614, issn 0022-5347, 8 p.Article